Vitrolife AB Total Assets

Latest as of June 2026: Skr11.30 Billion SEK ≈ $1.22 Billion USD

Vitrolife AB total assets. Based on the latest financial reports, Vitrolife AB (VITR) holds total assets worth Skr11.30 Billion SEK (≈ $1.22 Billion USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see how much is Vitrolife AB worth for the company's overall valuation and market capitalisation.

Total Assets of Vitrolife AB (2000–2025)

Total assets of Vitrolife AB from 2000 to 2025. This chart illustrates how Vitrolife AB's total assets have evolved over time, based on quarterly financial data. See VITR live share price for real-time trading data and today's change.

Vitrolife AB - Asset Composition Analysis

Vitrolife AB Total Assets Breakdown (December 2025)

Vitrolife AB total assets breakdown as of December 2025. Vitrolife AB's total assets of Skr11.30 Billion consist of 18.8% current assets and 81.2% non-current assets.

Asset Category	Amount (SEK)	% of Total Assets
Cash & Equivalents	Skr809.00 Million	7.3%
Accounts Receivable	Skr749.00 Million	6.7%
Inventory	Skr413.00 Million	3.7%
Property, Plant & Equipment	Skr515.00 Million	4.6%
Intangible Assets	Skr3.83 Billion	34.5%
Goodwill	Skr4.44 Billion	39.9%

Asset Composition Trend (2000–2025)

This chart illustrates how Vitrolife AB's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore working capital position of Vitrolife AB to assess how much short-term liquidity the company maintains relative to its equity base.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Vitrolife AB's current assets represent 18.8% of total assets in 2025, an increase from 0.0% in 2000.
Cash Position: Cash and equivalents constituted 7.3% of total assets in 2025, up from 6.7% in 2000.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 73.0% of total assets, an increase from 27.0% in 2000.
Asset Diversification: The largest asset category is goodwill at 39.9% of total assets.

Vitrolife AB Competitors by Total Assets

Key competitors of Vitrolife AB based on total assets are shown below.

Company	Country	Total Assets
Shenzhen New Industries Biomedical SHE:300832	China	CN¥9.58 Billion
Double Medical Technology Inc SHE:002901	China	CN¥5.03 Billion
BMC Medical Co. Ltd. A SHE:301367	China	CN¥3.59 Billion
SS Innovations International Inc. Common Stock NASDAQ:SSII	USA	$96.98 Million
Emvision Medical Devices Ltd AU:EMV	Australia	AU$24.94 Million
Sequana Medical NV BR:SEQUA	Belgium	€14.57 Million
Hironic Co. Ltd KQ:149980	Korea	₩80.01 Billion
DRGEM Corporation KQ:263690	Korea	₩131.65 Billion

Vitrolife AB - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	3.64	3.41	21.40
Quick Ratio	2.91	2.73	20.44
Cash Ratio	0.00	1.44	19.40
Working Capital	Skr1.59 Billion	Skr1.54 Billion	Skr5.01 Billion

Vitrolife AB - Advanced Valuation Insights

This section examines the relationship between Vitrolife AB's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	1.52
Latest Market Cap to Assets Ratio	0.15
Asset Growth Rate (YoY)	-36.2%
Total Assets	Skr11.12 Billion
Market Capitalization	$1.68 Billion USD

Valuation Analysis

Below Book Valuation: The market values Vitrolife AB's assets below their book value (0.15x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Vitrolife AB's assets decreased by 36.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Vitrolife AB (2000–2025)

The table below shows the annual total assets of Vitrolife AB from 2000 to 2025.

Year	Total Assets	Change
2025-12-31	Skr11.12 Billion ≈ $1.20 Billion	-36.24%
2024-12-31	Skr17.45 Billion ≈ $1.88 Billion	+6.84%
2023-12-31	Skr16.33 Billion ≈ $1.76 Billion	-20.54%
2022-12-31	Skr20.55 Billion ≈ $2.21 Billion	+5.78%
2021-12-31	Skr19.43 Billion ≈ $2.09 Billion	+742.87%
2020-12-31	Skr2.31 Billion ≈ $248.06 Million	+7.78%
2019-12-31	Skr2.14 Billion ≈ $230.16 Million	+25.99%
2018-12-31	Skr1.70 Billion ≈ $182.67 Million	+19.34%
2017-12-31	Skr1.42 Billion ≈ $153.08 Million	+13.75%
2016-12-31	Skr1.25 Billion ≈ $134.57 Million	+18.06%
2015-12-31	Skr1.06 Billion ≈ $113.99 Million	+8.92%
2014-12-31	Skr972.48 Million ≈ $104.65 Million	+99.36%
2013-12-31	Skr487.81 Million ≈ $52.50 Million	+5.54%
2012-12-31	Skr462.20 Million ≈ $49.74 Million	-0.98%
2011-12-31	Skr466.78 Million ≈ $50.23 Million	+8.71%
2010-12-31	Skr429.39 Million ≈ $46.21 Million	+19.50%
2009-12-31	Skr359.31 Million ≈ $38.67 Million	+4.86%
2008-12-31	Skr342.66 Million ≈ $36.88 Million	+14.43%
2007-12-31	Skr299.46 Million ≈ $32.23 Million	+10.49%
2006-12-31	Skr271.03 Million ≈ $29.17 Million	+28.23%
2005-12-31	Skr211.37 Million ≈ $22.75 Million	+13.92%
2004-12-31	Skr185.54 Million ≈ $19.97 Million	+0.84%
2003-12-31	Skr184.00 Million ≈ $19.80 Million	-2.40%
2002-12-31	Skr188.51 Million ≈ $20.29 Million	-42.53%
2001-12-31	Skr328.04 Million ≈ $35.30 Million	+89.38%
2000-12-31	Skr173.22 Million ≈ $18.64 Million	--

About Vitrolife AB

ST:VITR Sweden Medical Devices

Market Cap

$1.68 Billion

Skr15.60 Billion SEK

Market Cap Rank

#6521 Global

#103 in Sweden

Share Price

Skr115.20

Change (1 day)

+0.52%

52-Week Range

Skr85.20 - Skr151.00

All Time High

Skr560.50